Su-Fern Tan et al. demonstrated for the first time how targeting acid ceramidase reverses the aberrant lipid profile of AML, characterized by low ceramide levels and elevated S1P, which ultimately leads to cell death [12]. Here, ASAH1 is linked to acute myeloid leukemia.